Designing gene therapyMarch 31, 2016
Scientists at EMBL have increased the efficiency of a genome-engineering tool called Sleeping Beauty, which is showing promise in clinical trials of therapies for leukaemia and lymphoma. In a study published today in Nature Communications, they reveal structural information that they hope will ultimately result in better patient outcomes.
"Based on the structure, we designed new variants that are already 30% more efficient than the most efficient ones currently available," says Orsolya Barabas, who led the work at EMBL. "That may not sound like a lot, but for patients with only a few months' prognosis, waiting 3 weeks for a treatment is better than waiting a whole month."
Sleeping Beauty is a transposon, or 'jumping gene', currently being used in clinical trials for B-cell leukaemias and lymphomas. In these treatments, Sleeping Beauty is used to insert a gene into T-cells - white blood cells that help to track down and eliminate threats such as disease-causing microbes - harvested from a patient. The genetically modified T-cells are injected back into the patient, where their new gene enables them to seek out and destroy the cancer cells. The technique is cheaper and easier to apply than current approaches, which mainly rely on modified viruses as deliverymen, so it is rapidly moving into clinical practice, and attracting investment from the pharmaceutical industry.
A bottleneck of this method is that it takes time to engineer and select the therapeutic T-cells. The quicker the T-cells can be modified and transplanted back, the better the treatment prognosis for the patients, and the lower the costs. Until now, however, efforts to increase the treatment's efficiency were educated guesses, based on the structure of similar molecules. Franka Voigt, a postdoc in Barabas' lab, determined the structure of Sleeping Beauty's active domain. Working with Zoltán Ivics' lab at the Paul Ehrlich Institute in Germany, the EMBL scientists then designed changes to that structure to make it work better.
More efficient than CRISPR
Transposons like Sleeping Beauty have advantages for therapies that hinge on inserting a gene, compared to other genome engineering approaches such as CRISPR/Cas9. Researchers can make CRISPR/Cas9 cut the genome at a specific point - making it ideal for eliminating genetic errors - but it doesn't insert any genetic material; the gene is added separately, and is only one of several options available to the cell's machinery to repair the cut. By contrast, Sleeping Beauty inserts the extra genetic material directly into the genome - and the EMBL scientists' enhancements now make it even more efficient.
"Ideally, you'd want to combine the targeting of CRISPR and the efficiency of Sleeping Beauty - but that's proving very, very difficult," says Barabas, "so it makes sense to pursue the applications that each is best at, at least for the time being."
Efforts to direct Sleeping Beauty to insert its cargo at specific locations have so far been unsuccessful. It inserts the extra genetic material at random, so there is a risk - albeit a small one - that the addition could disrupt the cell's genome. To minimise this risk, the therapies currently being trialled involve carefully selecting which T-cells to inject back into a patient, which takes time.
The scientists are continuing to design mutations to try to increase Sleeping Beauty's efficiency even further. In parallel, Barabas' lab strives to uncover the structure of the whole molecule bound to the DNA that it acts upon, as this could provide insights for further improvements. Such future improvements could make Sleeping Beauty-based therapies feasible for other conditions such as solid tumours, where the current versions of Sleeping Beauty are not efficient enough.
European Molecular Biology Laboratory
Related Genome Articles:
An international consortium, with the participation of the Helmholtz Zentrum München, Plant Genome and Systems Biology Department (PGSB), has published methodologically significant data on the barley genome.
Looking for a better beer or single malt Scotch whiskey?
Chronic lung infections can be devastating for patients with cystic fibrosis (CF), and infection by Burkholderia cenocepacia, one of the most common species found in cystic fibrosis patients, is often antibiotic resistant.
Cells face a daunting task. They have to neatly pack a several meter-long thread of genetic material into a nucleus that measures only five micrometers across.
A study by San Diego Zoo Global reveals that the prospects for recovery of the critically endangered northern white rhinoceros -- of which only three individuals remain -- will reside with the genetic resources that have been banked at San Diego Zoo Global's Frozen Zoo®.
Precise, economical genome editing tools such as CRISPR have made it possible to make targeted changes in genes, which could be applied to human embryos to correct mutations, prevent disease, or alter traits.
How do pathogens such as bacteria or parasites manage to hide from their host's immune system?
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore and the Bioinformatics Institute, have developed SIFT 4G (SIFT for Genomes) -- a software that can lead to faster genome analysis.
Single-cell techniques have been used to investigate histone replacement and chromatin remodeling in developing oocytes.
Dinoflagellates live free-floating in the ocean or symbiotically with corals, serving up -- or as -- lunch to a host of mollusks, tiny fish and coral species.
Related Genome Reading:
Genome (The Extinction Files Book 2)
by A.G. Riddle (Author)
The thrilling conclusion to THE EXTINCTION FILES is finally here!
* * *
A code hidden in the human genome...
Will reveal the ultimate secret of human existence.
And could hold humanity's only hope of survival.
* * *
In 2003, the first human genome was sequenced. But the secrets it held were never revealed.
The truth was discovered thirty years ago, almost by accident. Dr. Paul Kraus had spent his entire career searching for what he called humanity's lost tribes--human ancestors who had gone extinct. When... View Details
Genome: The Autobiography of a Species in 23 Chapters
by Matt Ridley (Author)
The genome's been mapped.
But what does it mean?
Arguably the most significant scientific discovery of the new century, the mapping of the twenty-three pairs of chromosomes that make up the human genome raises almost as many questions as it answers. Questions that will profoundly impact the way we think about disease, about longevity, and about free will. Questions that will affect the rest of your life.
Genome offers extraordinary insight into the ramifications of this incredible breakthrough. By picking one newly discovered gene from each pair of chromosomes and... View Details
The Gene: An Intimate History
by Siddhartha Mukherjee (Author)
THE #1 NEW YORK TIMES BESTSELLER
A New York Times Notable Book
A Washington Post and Seattle Times Best Book of the Year
From the Pulitzer Prize-winning author of The Emperor of All Maladies—a fascinating history of the gene and “a magisterial account of how human minds have laboriously, ingeniously picked apart what makes us tick” (Elle).
“Dr. Siddhartha Mukherjee dazzled readers with his Pulitzer Prize-winning The Emperor of All Maladies in 2010. That achievement was evidently just a warm-up for... View Details
The Age of Genomes: Tales from the Front Lines of Genetic Medicine
by Steven Monroe Lipkin (Author), Jon Luoma (Author)
A leading geneticist explores what promises to be one of the most transformative advances in health and medicine in history
Almost every week, another exciting headline appears about new advances in the field of genetics. Genetic testing is experiencing the kind of exponential growth once seen with the birth of the Internet, while the plummeting cost of DNA sequencing makes it increasingly accessible for individuals and families.
Steven Lipkin and Jon Luoma posit that today’s genomics is like the last century’s nuclear physics: a powerful tool for good if used... View Details
Pandemic (The Extinction Files, Book 1)
by A.G. Riddle (Author)
Read the first novel in The Extinction Files--a two-book series that is now complete!
* * *
From A.G. Riddle, the worldwide bestselling author with OVER 3 MILLION COPIES SOLD, comes a sci-fi thriller readers are calling "addictive" and "an achievement that takes the genre to the next level."
In Africa, a mysterious outbreak spreads quickly. Teams from the CDC and WHO respond, but they soon learn that there is more to the epidemic than they believed. It may be the beginning of a global experiment--an event that will change the human race... View Details
Neanderthal Man: In Search of Lost Genomes
by Svante Pääbo (Author)
"[T]his book is a vibrant testimonial to what might be the greatest creation of modern humans: the scientific method." --Salon
Neanderthal Man tells the story of geneticist Svante Pääbo's mission to answer this question: what can we learn from the genomes of our closest evolutionary relatives? Beginning with the study of DNA in Egyptian mummies in the early 1980s and culminating in the sequencing of the Neanderthal genome in 2010, Neanderthal Man describes the events, intrigues, failures, and triumphs of these scientifically rich years through the lens of... View Details
Adam and the Genome: Reading Scripture after Genetic Science
by Scot McKnight (Author), Dennis R. Venema (Author), Daniel Harrell (Afterword), Tremper Longman III (Afterword)
Genomic science indicates that humans descend not from an individual pair but from a large population. What does this mean for the basic claim of many Christians: that humans descend from Adam and Eve?
Leading evangelical geneticist Dennis Venema and popular New Testament scholar Scot McKnight combine their expertise to offer informed guidance and answers to questions pertaining to evolution, genomic science, and the historical Adam. Some of the questions they explore include:
- Is there credible evidence for evolution?
- Do we descend from a population or are we the offspring of... View Details
Understanding the Human Genome Project (2nd Edition)
by Michael A. Palladino (Author)
Completion of the Human Genome Project is just the tip of the iceberg in our understanding of human genetics. How can information gathered during the Human Genome Project be used? This brief booklet explains in accessible language what readers need to understand about the Human Genome Project, including the background, findings, and social and ethical implications. The author, Michael Palladino, also includes relevant Web resources and exercises for readers. View Details
The Developing Genome: An Introduction to Behavioral Epigenetics
by David S. Moore (Author)
Why do we grow up to look, act, and feel as we do? Through most of the twentieth century, scientists and laypeople answered this question by referring to two factors alone: our experiences and our genes. But recent discoveries about how genes work have revealed a new way to understand the developmental origins of our characteristics. These discoveries have emerged from the new science of behavioral epigenetics--and just as the whole world has now heard of DNA, "epigenetics" will be a household word in the near future.
Behavioral epigenetics is important because it explains how our... View Details
The Mysterious World of the Human Genome
by Frank Ryan (Author)
The human genome is indeed a mysterious world, but, as this fascinating book shows, its vital secrets are now being uncovered. The latest studies are revealing exciting new discoveries, such as how the DNA and related chemical compounds in our cells work together to direct the processes of life. Scientists are not only unraveling how life evolved in the ancient past, but are also finding the keys to creating a healthier future.
How does the minuscule chemical cluster in each of our 100 trillion cells accomplish the amazing feat of creating and maintaining our bodies? Frank Ryan, a... View Details